Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by JustCheckingInon Jun 15, 2022 3:17pm
151 Views
Post# 34759135

RE:RE:RE:The ARC Dialysis win is PARADIGM SHIFTING!!!!!!!!!

RE:RE:RE:The ARC Dialysis win is PARADIGM SHIFTING!!!!!!!!!Today's trading , and this week's for that matter, is a lesson in extremely tight insider ownership and an absolute uncaring attitude towards promotion.

Insiders couldn't care less whether this was 30 cents or $3.00... They are sitting on a now commercialized BLOCKBUSTER and the day to day 8-10-15% increses are entirely inconsequential to them.

The buyout is coming. There are likely intense negotiations underway at this moment.

Everyone's Dialysis technology looks tired and antiquated relative to Dialco's and every major player from Baxter to Fresenius Knows it!!!

Could be any day now...Halt! ... Explosion!

The ARC deal screams buyout, absolutely screams it!!!
<< Previous
Bullboard Posts
Next >>